Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Find a clinical trial that's recruiting now
Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.
- 24,857
- trials recruiting now
- 14%
- of all US trials open to enrollment
- 52
- states with recruiting sites
A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.
Popular conditions
100 trials found
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Children's Hospital of Philadelphia
NCT02493478
US National OCS Heart Perfusion (OHP) Registry
TransMedics
NCT05915299
US National OCS Liver Perfusion (OLP) Registry
TransMedics
NCT05940857
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
John R van Nagell
NCT04473833
Stroke Thrombectomy and Aneurysm Registry
Medical University of South Carolina
NCT04994756
School Screening and Telemedicine Specialty Referral to Address Childhood Hearing Loss in Rural Kentucky
University of Arkansas
NCT05513833
Tracking Results of Ablations to Combat AF Registry Generation 2
AtriCure
NCT05111015
Prospective Case Collection Study for New Mammography Technologies
Hologic
NCT05199701
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
VA Office of Research and Development
NCT02915198
Quality of Pediatric Resuscitation in a Multicenter Collaborative
Children's Hospital of Philadelphia
NCT02708134
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Adela
NCT05366881
Platform of Randomized Adaptive Clinical Trials in Critical Illness
University Health Network, Toronto
NCT05440851
CSTOP Now! Child Sex Trafficking Stops With You
Ann Coker
NCT05722769
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Colorado Prevention Center
NCT06008197
Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease
The University of Texas Health Science Center, Houston
NCT04005976
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
The University of Texas Health Science Center, Houston
NCT05685745
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Duke University
NCT04278404
The Fourth Left Atrial Appendage Occlusion Study
Hamilton Health Sciences Corporation
NCT05963698
Gastroparesis Outcome Longitudinal Database Enrolled Numerically
University of Louisville
NCT03876288
Pulmonary Hypertension Association Registry
Pulmonary Hypertension Association
NCT04071327
Creating VIP Corps to Reduce Maternal Deaths
Ann Coker
NCT06089109
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
Potrero Medical
NCT04669548
MOON Shoulder Instability-Cohort of Patients Undergoing Operative Treatment.
Carolyn M Hettrich
NCT02075775
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
Veracyte
NCT06426628
Motiva Implants® Post-Approval Study
Motiva USA
NCT06938399
Left vs Left Randomized Clinical Trial
Baylor College of Medicine
NCT05650658
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
AstraZeneca
NCT07431281
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
Jason Sperry
NCT04100564
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
W.L.Gore & Associates
NCT06218875
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
Arkansas Children's Hospital Research Institute
NCT05550298
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Exact Sciences Corporation
NCT06401421
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
Stanford University
NCT05612750
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Janssen Research & Development
NCT05552222
Spinal Cord Injury Registry - North American Clinical Trials Network
Robert G. Grossman, MD
NCT00178724
Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
Boston Scientific Corporation
NCT06827262
Complex Adult Deformity Surgery (CADS)
International Spine Study Group Foundation
NCT04194138
Pan Tumor Rollover Study
Bristol-Myers Squibb
NCT03899155
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
Johns Hopkins University
NCT04989790
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Merck Sharp & Dohme
NCT06925737
EXoPERT EMERALD Clinical Study
EXoPERT
NCT07186296
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
North American Consortium for Histiocytosis
NCT02205762
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
Exelixis
NCT05176483
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Merck Sharp & Dohme
NCT06136624
A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age
Vaxcyte
NCT07365826
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Kura Oncology
NCT07007312
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
NYU Langone Health
NCT04474223
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
BioNTech SE
NCT06712316
Empathic Communication Skills (ECS) Training
Memorial Sloan Kettering Cancer Center
NCT05456841
Prevail Global Study
Medtronic Vascular
NCT06535854
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Merck Sharp & Dohme
NCT06312176
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Merck Sharp & Dohme
NCT06136559
The PEERLESS II Study
Inari Medical
NCT06055920
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT
Major Extremity Trauma Research Consortium
NCT04678154
Mobile Apps for Preschool Parents (MAPP) Study
Pamela Hull
NCT06520072
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
AstraZeneca
NCT07221253
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
Genmab
NCT06191744
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Merck Sharp & Dohme
NCT04165798
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Merck Sharp & Dohme
NCT06717347
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
University of Calgary
NCT05219110
The Ailliance Post-Market Clinical Study
Medtronic Spinal and Biologics
NCT05856370
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
State University of New York at Buffalo
NCT00682695
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Abbott Medical Devices
NCT04071847
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
United Therapeutics
NCT06388421
Beat Childhood Cancer Specimen Banking and Data Registry
Giselle Sholler
NCT04715178
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Merck Sharp & Dohme
NCT07060807
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Bristol-Myers Squibb
NCT06561386
Brain, Blood And Clot or Tissue Registry And Collaboration
Justin Fraser
NCT03153683
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry
SCAD Alliance
NCT04496687
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
Cleerly
NCT06713239
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
AbbVie
NCT06543914
A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)
Merck Sharp & Dohme
NCT07216482
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
BicycleTx Limited
NCT06225596
An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
U.S. Army Medical Research and Development Command
NCT04180930
Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Sanofi
NCT05769777
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
Ascendis Pharma Endocrinology Division A/S
NCT05820672
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Eli Lilly and Company
NCT07353931
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
AstraZeneca
NCT04862663
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
GlaxoSmithKline
NCT05855200
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Merck Sharp & Dohme
NCT06077760
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
GlaxoSmithKline
NCT06256588
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
DualityBio
NCT05914116
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Daiichi Sankyo
NCT06161025
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
AstraZeneca
NCT05211895
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Boston Scientific Corporation
NCT07069738
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Medical Devices
NCT06526195
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
AbbVie
NCT06236438
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
University of Louisville
NCT03670524
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
AstraZeneca
NCT06868277
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
Gilead Sciences
NCT03547973
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
Merck Sharp & Dohme
NCT07218029
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
VastBiome
NCT05037825
Department of Defense PTSD Adaptive Platform Trial - Master Protocol
Global Coalition for Adaptive Research
NCT05422612
Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
HELP for NOWS Consortium
NCT07278375
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Janssen Research & Development
NCT06208150
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
BrioHealth Solutions
NCT06310031
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
BeiGene
NCT05100862
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
SWOG Cancer Research Network
NCT05642611
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Zimmer Biomet
NCT05787821
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Shanghai Junshi Bioscience Co.
NCT06095583
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Sunnybrook Health Sciences Centre
NCT05427370
Read our methodology - how recruiting status is sourced and refreshed from the public registry.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.